LexisNexis unveiled Protégé, a natural language AI assistant that translates questions like “What are the top M&A targets in biotech?” into patent analytics insights. The firm positions the new offering as eliminating the need for users to master complex database syntax in the company’s PatentSight+ platform. The assistant parses a user’s prompt, maps it to…
In 2024, the US and Europe led in pharma value creation while GLP-1s disrupted the landscape
GLP-1 juggernauts Eli Lilly and Novo Nordisk, whose combined $1.18 trillion market cap now exceeds Johnson & Johnson, AbbVie, and Merck combined, have staked their claim as stock market darlings. This momentum is particularly evident in Novo Nordisk’s remarkable trajectory, reaching a $604 billion market capitalization by March 2024 and securing its position as the…